Medicare: Considerations for Adding a Prescription Drug Benefit

Testimony issued by the General Accounting Office with an abstract that begins "Pursuant to a congressional request, GAO discussed: (1) the factors contributing to the growth in prescription drug spending for both the general population and Medicare beneficiaries and efforts to control that growth; and (2) benefit design and implementation issues to be considered in deliberations about adding a new prescription drug benefit to the Medicare Program.